Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK – Analysis of National Data.

D Azzopardi, B Strohm, L Linsell, A Hobson, E Juszczak , JJ Kurinczuk , P Brocklehurst , AD Edwards, UK TOBY Cooling Register

Research output: Contribution to journalArticle (Academic Journal)peer-review

78 Citations (Scopus)
279 Downloads (Pure)

Abstract

Background
Delay in implementing new treatments into clinical practice results in considerable health and economic opportunity costs. Data from the UK TOBY Cooling Register provides the opportunity to examine how one new effective therapy for newborn infants suspected of suffering asphyxial encephalopathy – therapeutic hypothermia- was implemented in the UK.

Methodology/Principal Findings
We analysed returned data forms from inception of the Register in December 2006 to the end of July 2011. Data forms were received for 1384 (67%) of the 2069 infants registered. The monthly rate of notifications increased from median {IQR} 18 {15–31} to 33 {30–39} after the announcement of the results of the recent TOBY trial, and to 50 {36–55} after their publication. This rate further increased to 70 {64–83} following official endorsement of the therapy, and is now close to the expected numbers of eligible infants. Cooling was started at 3.3 {1.5–5.5} hours after birth and the time taken to achieve the target 33–34°C rectal temperature was 1 {0–3} hours. The rectal temperature was in the target range in 83% of measurements. From 2006 to 2011 there was evidence of extension of treatment to slightly less severely affected infants. 278 of 1362 (20%) infants died at 2.9 {1.4–4.1} days of age. The rates of death fell slightly over the period of the Register and, at two years of age cerebral palsy was diagnosed in 22% of infants; half of these were spastic bilateral. Factors independently associated with adverse outcome were clinical seizures prior to cooling (p<0.001) and severely abnormal amplitude integrated EEG (p<0.001).

Conclusions/Significance
Therapeutic hypothermia was implemented appropriately within the UK, with significant benefit to patients and the health economy. This may be due in part to participation by neonatal units in clinical trials, the establishment of the national Register, and its endorsement by advisory bodies.

Original languageEnglish
Article numbere38504
Number of pages11
JournalPLoS ONE
Volume7
Issue number6
DOIs
Publication statusPublished - 13 Jun 2012

Fingerprint Dive into the research topics of 'Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK – Analysis of National Data.'. Together they form a unique fingerprint.

Cite this